Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 14 (RPL35AP14)

Target: RPL35AP14
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L35a pseudogene 14 (RPL35AP14) is a processed pseudogene corresponding to the functional ribosomal protein L35a gene (RPL35A), which encodes a structural component of the large 60S subunit of the ribosome. As a pseudogene, RPL35AP14 does not produce a functional protein and lacks a known biological or disease-related function. Pseudogenes such as RPL35AP14 are common in the human genome as byproducts of gene duplication or retrotransposition and are generally not considered therapeutic targets[4].

Other names: RPL35A_4_569RPL35AP14

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 14 (RPL35AP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 14 (RPL35AP14).

Explore the full profile